Abstract
Objective: Calmodulin (CaM) plays a key role in the orchestration of Ca2+ signaling events, and its regulation is considered an important component of cellular homeostasis. The control of uterine smooth muscle function is largely dependent on the regulation of Ca2+ and CaM signaling. The objective of this study was to investigate the expression, function, and regulation of CaM regulatory proteins in myometrium during pregnancy. Study Design: Myometrium was obtained from nonpregnant women and 4 groups of pregnant women at the time their primary cesarean delivery: (i) preterm not in labor, (ii) preterm in labor with clinical and/or histological diagnosis of chorioamnionitis, (3) term not in labor; and (4) term in labor. The effect of perinatal inflammation on pcp4/pep-19 expression was evaluated in a mouse model of Ureaplasma parvum-induced chorioamnionitis. Human myometrial cells stably expressing wild-type and mutant forms of PCP4/PEP-19 were used in the evaluation of agonist-induced intracellular Ca2+ mobilization. Results: Compared to other CaM regulatory proteins, PCP4/PEP-19 transcripts were more abundant in human myometrium. The expression of PCP4/PEP-19 was lowest in myometrium of women with preterm pregnancy and chorioamnionitis. In the mouse uterus, pcp4/pep-19 expression was lower in late compared to mid-gestation and decreased in mice injected intra-amniotic with Ureaplasma parvum. In myometrial smooth muscle cells, tumor necrosis factor alpha and progesterone decreased and PCP4/PEP-19 promoter activity increased. Finally, the overexpression of PCP4/PEP-19 reduced agonist-induced intracellular Ca2+ levels in myometrial cells. Conclusion: The decreased expression of PCP4/PEP-19 in myometrium contributes to a loss of quiescence in response to infection-induced inflammation at preterm pregnancy.
Similar content being viewed by others
References
Garfield RE, Saade G, Buhimschi C, et al. Control and assessment of the uterus and cervix during pregnancy and labour. Hum Reprod Update. 1998;4(5):673–695.
Norwitz ER, Robinson JN, Challis JR. The control of labor. N EnglJMed. 1999;341(9):660–666.
Taussig R, Gilman AG. Mammalian membrane-bound adenylyl cyclases. J Biol Chem. 1995;270(1):1–4.
Beckingham K, Lu AQ, Andruss BF. Calcium-binding proteins and development. Biometals. 1998;11(4):359–373.
Landry J, Crete P, Lamarche S, Chretien P. Activation of Ca2+-dependent processes during heat shock: role in cell thermoresistance. Radiat Res. 1988;113(3):426–436.
Pierce SK, Politis AD, Cronkite DH, Rowland LM, Smith LH Jr. Evidence of calmodulin involvement in cell volume recovery following hypo-osmotic stress. Cell Calcium. 1989;10(3):159–169.
Lee A, Wong ST, Gallagher D, et al. Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature. 1999;399(6732):155–159.
Leonard AS, Lim IA, Hemsworth DE, Horne MC, Hell JW. Calcium/calmodulin-dependent protein kinase II is associated with the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1999;96(6):3239–3244.
Gerendasy DD, Herron SR, Watson JB, Sutcliffe JG. Mutational and biophysical studies suggest RC3/neurogranin regulates calmodulin availability. J Biol Chem. 1994;269(35):22420–22426.
Putkey JA, Kleerekoper Q, Gaertner TR, Waxham MN. A new role for IQ motif proteins in regulating calmodulin function. J Biol Chem. 2003;278(50):49667–49670.
Slemmon JR, Feng B, Erhardt JA. Small proteins that modulate calmodulin-dependent signal transduction: effects of PEP-19, neuromodulin, and neurogranin on enzyme activation and cellular homeostasis. Mol Neurobiol. 2000;22(1–3):99–113.
Kanamori T, Takakura K, Mandai M, et al. PEP-19 overexpression in human uterine leiomyoma. Mol Hum Reprod. 2003;9(11):709–717.
Slemmon JR, Morgan JI, Fullerton SM, Danho W, Hilbush BS, Wengenack TM. Camstatins are peptide antagonists of calmodulin based upon a conserved structural motif in PEP-19, neurogranin, andneuromodulin. J Biol Chem. 1996;271(27):15911–15917.
Iwamoto K, Bundo M, Yamamoto M, Ozawa H, Saito T, Kato T. Decreased expression of NEFH and PCP4/PEP19 in the prefrontal cortex of alcoholics. Neurosci Res. 2004;49(4):379–385.
Utal AK, Stopka AL, Roy M, Coleman PD. PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease. Neuroscience. 1998;86(4):1055–1063.
Skold K, Svensson M, Nilsson A, et al. Decreased striatal levels of PEP-19 following MPTP lesion in the mouse. J Proteome Res. 2006;5(2):262–269.
Xie YY, Sun MM, Lou XF, et al. Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy. J Pharmacol Sci. 2014;125(3):274–282.
Prakash K, Pirozzi G, Elashoff M, et al. Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc Natl Acad Sci USA. 2002;99(11):7598–7603.
Souda M, Umekita Y, Abeyama K, Yoshida H. Gene expression profiling during rat mammary carcinogenesis induced by 7,12-dimethylbenz[a]anthracene. Int J Cancer. 2009;125(6):1285–1297.
Felizola SJ, Nakamura Y, Ono Y, et al. PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues. J Mol Endocrinol. 2014;52(2):159–167.
Hamada T, Souda M, Yoshimura T, et al. Anti-apoptotic effects of PCP4/PEP19 in human breast cancer cell lines: a novel oncotarget. Oncotarget. 2014;5(15):6076–6086.
Visser E, Franken IA, Brosens LA, Ruurda JP, van Hillegersberg R. Prognostic gene expression profiling in esophageal cancer: a systematic review. Oncotarget. 2017;8(3):5566–5577.
Harashima S, Wang Y, Horiuchi T, Seino Y, Inagaki N. Purkinje cell protein 4 positively regulates neurite outgrowth and neurotransmitter release. J Neurosci Res. 2011;89(10):1519–1530.
Mouton-Liger F, Thomas S, Rattenbach R, et al. PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca(2+)/calmodulin-dependent kinase II-delta activation in mouse models of Down syndrome. J Comp Neurol. 2011;519(14):2779–2802.
Wei P, Blundon JA, Rong Y, Zakharenko SS, Morgan JI. Impaired locomotor learning and altered cerebellar synaptic plasticity in pep-19/PCP4-null mice. Mol Cell Biol. 2011;31(14):2838–2844.
Kim EE, Shekhar A, Lu J, et al. PCP4 regulates Purkinje cell excitability and cardiac rhythmicity. J Clin Invest. 2014;124(11):5027–5036.
Erhardt JA, Legos JJ, Johanson RA, Slemmon JR, Wang X. Expression of PEP-19 inhibits apoptosis in PC12 cells. Neuroreport. 2000;11(17):3719–3723.
Kanazawa Y, Makino M, Morishima Y, Yamada K, Nabeshima T, Shirasaki Y. Degradation of PEP-19, a calmodulin-binding protein, by calpain is implicated in neuronal cell death induced by intracellular Ca2+ overload. Neuroscience. 2008;154(2):473–481.
Wang X, Xiong LW, El Ayadi A, Boehning D, Putkey JA. The calmodulin regulator protein, PEP-19, sensitizes ATP-induced Ca2+ release. J Biol Chem. 2013;288(3):2040–2048.
Weiner CP, Mason CW, Dong Y, Buhimschi IA, Swaan PW, Buhimschi CS. Human effector/initiator gene sets that regulate myometrial contractility during term and preterm labor. Am J Obstet Gynecol. 2010;202(5):474 e1–20.
Buhimschi CS, Dulay AT, Abdel-Razeq S, et al. Fetal inflammatory response in women with proteomic biomarkers characteristic of intra-amniotic inflammation and preterm birth. BJOG. 2009;116(2):257–267.
Redline RW, Faye-Petersen O, Heller D, et al. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2003;6(5):435–448.
Normann E, Lacaze-Masmoπteil T, Eaton F, Schwendimann L, Gressens P, Thebaud B. A novel mouse model of Ureaplasma-induced perinatal inflammation: effects on lung and brain injury. PediatrRes. 2009;65(4):430–436.
Condon J, Yin S, Mayhew B, et al. Telomerase immortalization of human myometrial cells. Biol Reprod. 2002;67(2):506–514.
Xiao J, Wu Y, Chen R, et al. Expression of Pcp4 gene during osteogenic differentiation of bone marrow mesenchymal stem cells in vitro. Mol Cell Biochem. 2008;309(1–2):143–150.
Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64(15):5245–5250.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(—delta delta C(T)) method. Methods. 2001;25(4):402–408.
Cox C, Saxena N, Watt AP, et al. The common vaginal commensal bacterium Ureaplasma parvum is associated with chorioam-nionitis in extreme preterm labor. J Matern Fetal Neonatal Med. 2016;29(22):3646–3651.
Gerber S, Vial Y, Hohlfeld P, Witkin SS. Detection of Urea-plasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery. J Infect Dis. 2003;187(3):518–521.
Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med. 1988;319(15):972–978.
Knox CL, Cave DG, Farrell DJ, Eastment HT, Timms P. The role of Ureaplasma urealyticum in adverse pregnancy outcome. Aust NZ J Obstet Gynaecol. 1997;37(1):45–51.
Namba F, Hasegawa T, Nakayama M, et al. Placental features of chorioamnionitis colonized with Ureaplasma species in preterm delivery. Pediatr Res. 2010;67(2):166–172.
Sweeney EL, Kallapur SG, Gisslen T, et al. Placental infection with ureaplasma species is associated with histologic chorioam-nionitis and adverse outcomes in moderately preterm and latepreterm infants. J Infect Dis. 2016;213(8):1340–1347.
Read CP, Word RA, Ruscheinsky MA, Timmons BC, Mahendroo MS. Cervical remodeling during pregnancy and parturition: molecular characterization of the softening phase in mice. Reproduction. 2007;134(2):327–340.
Murr SM, Stabenfeldt GH, Bradford GE, Geschwind II. Plasma progesterone during pregnancy in the mouse. Endocrinology. 1974;94(4):1209–1211.
Soloff MS, Jeng YJ, Izban MG, et al. Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reprod Sci. 2011;18(8):781–797.
Wang X, Putkey JA. PEP-19 modulates calcium binding to calmodulin by electrostatic steering. Nat Commun. 2016;7:13583.
Sanborn BM. Ion channels and the control ofmyometrial electrical activity. Semin Perinatol. 1995;19(1):31–40.
Sanborn BM. Relationship of ion channel activity to control of myometrial calcium. J Soc Gynecol Investig. 2000;7(1):4–11.
Sanborn BM. Hormones and calcium: mechanisms controlling uterine smooth muscle contractile activity. The Litchfield Lecture. Exp Physiol. 2001;86(2):223–237.
Ku CY, Qian A, Wen Y, Anwer K, Sanborn BM. Oxytocin stimulates myometrial guanosine triphosphatase and phospholipase-C activities via coupling to G alpha q/11. Endocrinology. 1995;136(4):1509–1515.
McCullar JS, Larsen SA, Millimaki RA, Filtz TM. Calmodulin is a phospholipase C-beta interacting protein. J Biol Chem. 2003;278(36):33708–33713.
Taylor CW, Laude AJ. IP3 receptors and their regulation by calmodulin and cytosolic Ca2+. Cell Calcium. 2002;32(5–6):321–334.
Zhu MX. Multiple roles of calmodulin and other Ca(2+)-binding proteins in the functional regulation of TRP channels. Pflugers Arch. 2005;451(1):105–115.
Acknowledgments
The authors thank Dr J. Condon (Wayne State University. Detroit, MI) for providing hTERT-HM cells and Dr H. Burkin (University of Nevada, Reno, NV, USA) for providing the PHUSMC-HTRT.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
He, L., Lee, G.T., Zhou, H. et al. Expression, Regulation, and Function of the Calmodulin Accessory Protein PCP4/PEP-19 in Myometrium. Reprod. Sci. 26, 1650–1660 (2019). https://doi.org/10.1177/1933719119828072
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719119828072